Cargando…

Biomarkers and Tools for Predicting Alzheimer’s Disease in the Preclinical Stage

Alzheimer’s disease (AD) is the only leading cause of death for which no disease-modifying therapy is currently available. Over the past decade, a string of disappointing clinical trial results has forced us to shift our focus to the preclinical stage of AD, which represents the most promising thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Tao-Ran, Yang, Qin, Hu, Xiaochen, Han, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878962/ https://www.ncbi.nlm.nih.gov/pubmed/34030620 http://dx.doi.org/10.2174/1570159X19666210524153901

Ejemplares similares

MCP-1 levels in astrocyte-derived exosomes are changed in preclinical stage of Alzheimer's disease
por: Wang, Ting, et al.
Publicado: (2023)

Systematic review protocol for assessing central auditory functions of Alzheimer’s disease and its preclinical stages
por: Jayakody, Dona M P, et al.
Publicado: (2020)

Auditory electrophysiological assessments of Alzheimer’s disease and preclinical stages: protocol for a systematic review and meta-analysis
por: Tarawneh, Hadeel Y, et al.
Publicado: (2020)

Prediction of Conversion From Amnestic Mild Cognitive Impairment to Alzheimer's Disease Based on the Brain Structural Connectome
por: Sun, Yu, et al.
Publicado: (2019)

Vascular biomarkers to predict response to exercise in Alzheimer's disease: the study protocol
por: Li, Danni, et al.
Publicado: (2016)

Falls: a marker of preclinical Alzheimer disease: a cohort study protocol
por: Bollinger, Rebecca M, et al.
Publicado: (2021)

Identification of Blood Biomarkers for Alzheimer's Disease Through Computational Prediction and Experimental Validation
por: Yao, Fang, et al.
Publicado: (2019)

Multi-Dimensional Diffusion Tensor Imaging Biomarkers for Cognitive Decline From the Preclinical Stage: A Study of Post-stroke Small Vessel Disease
por: Du, Jing, et al.
Publicado: (2021)

Phosphorylated Tau 181 Serum Levels Predict Alzheimer’s Disease in the Preclinical Stage
por: Qin, Wei, et al.
Publicado: (2022)

Association of plasma apolipoproteins and levels of inflammation-related factors with different stages of Alzheimer’s disease: a cross-sectional study
por: Wang, Ting, et al.
Publicado: (2022)

Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
por: Kivisäkk, Pia, et al.
Publicado: (2023)

Sarcopenia and Muscle Functions at Various Stages of Alzheimer Disease
por: Ogawa, Yusuke, et al.
Publicado: (2018)

Lipids as Early and Minimally Invasive Biomarkers for Alzheimer’s Disease
por: Casas-Fernández, Esther, et al.
Publicado: (2022)

Sino Longitudinal Study on Cognitive Decline (SILCODE): protocol for a Chinese longitudinal observational study to develop risk prediction models of conversion to mild cognitive impairment in individuals with subjective cognitive decline
por: Li, Xuanyu, et al.
Publicado: (2019)

Abnormal Temporal Slowing on EEG Findings in Preclinical Alzheimer’s Disease Patients With the ApoE4 Allele: A Pilot Study
por: Kim, Nathan N, et al.
Publicado: (2023)

The Predicted Key Molecules, Functions, and Pathways That Bridge Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)
por: Tao, Ye, et al.
Publicado: (2020)

Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing
por: Ketchum, Fred B., et al.
Publicado: (2022)

P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
por: Lantero‐Rodriguez, Juan, et al.
Publicado: (2021)

Potential Roles of α-amylase in Alzheimer’s Disease: Biomarker and Drug Target
por: Chen, Win Ning, et al.
Publicado: (2022)

Progress in blood biomarkers of subjective cognitive decline in preclinical Alzheimer's disease
por: Yu, Xianfeng, et al.
Publicado: (2023)

Early Stages of Alzheimer's Disease: Evolving the Care Team for Optimal Patient Management
por: Galvin, James E., et al.
Publicado: (2021)

MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study
por: Richard, Edo, et al.
Publicado: (2013)

Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal Carcinoma
por: Yang, Yadi, et al.
Publicado: (2019)

New Insights Into the Pathogenesis of Alzheimer's Disease
por: Fan, Liyuan, et al.
Publicado: (2020)

Blood biomarkers indicate that the preclinical stages of Alzheimer's disease present overlapping molecular features
por: Di Costanzo, Alfonso, et al.
Publicado: (2020)

CSF biomarkers for early-onset Alzheimer's disease in Chinese population from PUMCH dementia cohort
por: Lei, Dan, et al.
Publicado: (2023)

Progression of Cerebellar Atrophy in Spinocerebellar Ataxia Type 2 Gene Carriers: A Longitudinal MRI Study in Preclinical and Early Disease Stages
por: Nigri, Anna, et al.
Publicado: (2020)

BHARAT: An Integrated Big Data Analytic Model for Early Diagnostic Biomarker of Alzheimer's Disease
por: Sharma, Ankita, et al.
Publicado: (2019)

The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial
por: Abdullah, Laila, et al.
Publicado: (2020)

Case Report: Coexistence of Anti-AMPA Receptor Encephalitis and Positive Biomarkers of Alzheimer's Disease
por: Song, Yu, et al.
Publicado: (2021)

Integration of amyloid-β oligomerization tendency as a plasma biomarker in Alzheimer's disease diagnosis
por: Pyun, Jung-Min, et al.
Publicado: (2023)

Identification of the Early Stage of Alzheimer's Disease Using Structural MRI and Resting-State fMRI
por: Hojjati, Seyed Hani, et al.
Publicado: (2019)

The Differences of Serum Metabolites Between Patients With Early-Stage Alzheimer's Disease and Mild Cognitive Impairment
por: Weng, Wei-Chieh, et al.
Publicado: (2019)

3D genome-selected microRNAs to improve Alzheimer's disease prediction
por: Li, Keyi, et al.
Publicado: (2023)

Validity of CSF alpha-synuclein to predict psychosis in prodromal Alzheimer's disease
por: Monge-García, Sonia, et al.
Publicado: (2023)

Long Longitudinal Tract Lesion Contributes to the Progression of Alzheimer's Disease
por: Luo, Caimei, et al.
Publicado: (2020)

Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers
por: Mattsson-Carlgren, Niklas, et al.
Publicado: (2023)

Measuring cognition and function in the preclinical stage of Alzheimer's disease
por: Weintraub, Sandra, et al.
Publicado: (2018)

Electromagnetic signatures of the preclinical and prodromal stages of Alzheimer’s disease
por: Nakamura, Akinori, et al.
Publicado: (2018)

The Jrecan Device: Preclinical Data of a Novel Thrombectomy Device in Acute Thromboembolism Model of Beagle Dogs
por: Li, Chen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q1dk4hv9tem441is4hqkv2ovh4